AIM ImmunoTech Inc. vs. Amgen Inc
AIM ImmunoTech Inc. and Amgen Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AIM | AMGN | |
|---|---|---|
| Market Cap | $4.79 million | $237.36 billion |
AMGN leads on 1 of 1 size & scale factors.
Dividend
| AIM | AMGN | |
|---|---|---|
| Dividend Yield | — | 2.28% |
AIM and AMGN split the dividend factors evenly.
Risk & Sentiment
| AIM | AMGN | |
|---|---|---|
| Short Interest | 0.24% | 1.66% |
AIM leads on 1 of 1 risk & sentiment factors.
Dig deeper: AIM overview, AIM financials, AMGN overview, AMGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
